HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 29 filers reported holding HORIZON PHARMA INVT LTD in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $820,000 | -1.4% | 8,910 | 0.0% | 0.01% | -12.5% |
| Q4 2017 | $832,000 | -33.5% | 8,910 | -35.4% | 0.01% | -27.3% |
| Q3 2017 | $1,251,000 | -52.7% | 13,800 | -54.8% | 0.01% | -54.2% |
| Q2 2017 | $2,644,000 | -14.3% | 30,500 | -9.5% | 0.02% | -11.1% |
| Q1 2017 | $3,085,000 | -4.3% | 33,720 | 0.0% | 0.03% | 0.0% |
| Q4 2016 | $3,224,000 | -1.6% | 33,720 | 0.0% | 0.03% | -20.6% |
| Q3 2016 | $3,277,000 | +6.6% | 33,720 | 0.0% | 0.03% | +54.5% |
| Q2 2016 | $3,073,000 | +6.4% | 33,720 | 0.0% | 0.02% | +4.8% |
| Q1 2016 | $2,889,000 | – | 33,720 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|